ResearcherUniversity of British ColumbiaActive in the last 2 years
James D. Johnson
Matched on ORCID iD 0000-0002-7523-9433; OpenAlex author ID A5055826409, A5128591627. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 14
2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 7
- Endogenous insulin mediates dynamic coordination between pancreatic cancer and systemic metabolism Co-author DOI 10.64898/2026.08.26.745597↗
- New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical challenge, and future directions. Co-author DOI 10.3389/fgstr.2025.1645459↗
- Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Co-author DOI 10.1016/j.cmet.2023.10.003↗
- Islet amyloid polypeptide does not suppress pancreatic cancer. Co-author DOI 10.1016/j.molmet.2023.101667↗
- Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-cell transcriptomics. Co-author DOI 10.1186/s40170-022-00282-z↗
- Endogenous Hyperinsulinemia Contributes to Pancreatic Cancer Development. Last author DOI 10.1016/j.cmet.2019.07.003↗
- Effects of insulin on human pancreatic cancer progression modeled in vitro. Last author DOI 10.1186/1471-2407-14-814↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- David F. Schaeffer · 6 shared papers, 2019–2026 · strength 1.09
- Paper New-onset diabetes as an emerging risk group for early detection of pancreatic cancer: current evidence, clinical chall… DOI 10.3389/fgstr.2025.1645459↗
- Paper Endogenous insulin mediates dynamic coordination between pancreatic cancer and systemic metabolism DOI 10.64898/2026.08.26.745597↗
- Paper Islet amyloid polypeptide does not suppress pancreatic cancer. DOI 10.1016/j.molmet.2023.101667↗
- Janel L. Kopp · 5 shared papers, 2019–2026 · strength 0.81
- Paper Endogenous insulin mediates dynamic coordination between pancreatic cancer and systemic metabolism DOI 10.64898/2026.08.26.745597↗
- Paper Islet amyloid polypeptide does not suppress pancreatic cancer. DOI 10.1016/j.molmet.2023.101667↗
- Paper Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme product… DOI 10.1016/j.cmet.2023.10.003↗
- Daniel John Renouf · 2 shared papers, 2025–2026 · strength 0.53
- Jeffrey S.H. Lin · 2 shared papers, 2023–2026 · strength 0.39
- Anni M.Y. Zhang · 3 shared papers, 2019–2023 · strength 0.37
- Paper Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme product… DOI 10.1016/j.cmet.2023.10.003↗
- Paper Effects of hyperinsulinemia on pancreatic cancer development and the immune microenvironment revealed through single-ce… DOI 10.1186/s40170-022-00282-z↗
- Paper Endogenous Hyperinsulinemia Contributes to Pancreatic Cancer Development. DOI 10.1016/j.cmet.2019.07.003↗
- Joanna M. Karasinska · 1 shared paper, 2025 · strength 0.28
- Lan Valerie Tao · 1 shared paper, 2025 · strength 0.28
- Seth J. Parker · 1 shared paper, 2026 · strength 0.24
- Austin J. Taylor · 1 shared paper, 2023 · strength 0.19
- C. Bruce Verchere · 1 shared paper, 2023 · strength 0.19
- Shilpa Patil · 1 shared paper, 2023 · strength 0.14
- Hong Li · 1 shared paper, 2022 · strength 0.13
- Michelle Chan · 1 shared paper, 2014 · strength 0.04
- Garth L. Warnock · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.